Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENYK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,980
Award facts
- Contract value 100% obligated
- $13,979.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,979.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 14, 2026, with an ultimate completion date of January 16, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Department of Defense's medical supply chain, leveraging its registration in the System for Award Management since 2001 to provide comprehensive pharmaceutical products and medical consumables to federal agencies.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 contract awarded in November 2025 that positions the company as a regional prime vendor contractor. The PPV-G GEN V program, part of a broader $30.3 billion acquisition strategy, authorizes DLA to issue delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's extensive product portfolio, including oncology treatments, specialty pharmaceuticals, emergency medications, and routine pharmaceuticals, enables the company to fulfill the diverse and specialized requirements of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FENYK?
SPE2DU26FENYK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DU26FENYK worth?
The government has obligated $13,980 on SPE2DU26FENYK.
Is contract SPE2DU26FENYK an order under another contract?
Yes. SPE2DU26FENYK is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENYK competed?
The extent of competition for SPE2DU26FENYK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award